Gratia Capital’s PetMed Express PETS Stock Holding History

Gratia Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-42,500	Closed	-$1.93M	–	47
2017 Q4	$1.93M	Buy	+42,500	New	+$1.67M	0.48%	32

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Gratia Capital's PETS Position: Q4 2018 in Review

Gratia Capital sold out of PetMed Express (PETS) in Q4 2018, closing a stake of 34,453 shares — an estimated $1.14M sold.

Gratia Capital first reported a position in PETS in Q3 2017 and held it in 3 quarters. The position peaked at $14.1M in Q4 2017. 200 funds tracked by Wall St. Rank hold PETS as of Q4 2018.

Gratia Capital reported no remaining PetMed Express position as of Q4 2018 after selling out during the quarter.
Gratia Capital sold 34,453 PetMed Express shares in Q4 2018, an estimated $1.14M.
Gratia Capital first reported a position in PetMed Express in Q3 2017 and held it in 3 quarters.
Gratia Capital's PetMed Express position peaked at $14.1M in Q4 2017.
200 funds tracked by Wall St. Rank held PetMed Express as of Q4 2018.

Based on Gratia Capital's 13F filing for Q4 2018, filed 13 Feb 2019.